Announcement on Voluntary Disclosure of Subsidiary’s YKYY029 Injection Obtaining Clinical Trial Approval from the National Medical Products Administration
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment